MicroRNA‑92a overexpression promotes the osteogenic differentiation of bone mesenchymal stem cells by impeding Smad6‑mediated runt‑related transcription factor 2 degradation

Yan,Xu; Wang,Hao; Li,Yufei; Jiang,Yuxin; Shao,Qingdong; Xu,Weidong

doi:10.3892/mmr.2018.8829

MicroRNA‑92a overexpression promotes the osteogenic differentiation of bone mesenchymal stem cells by impeding Smad6‑mediated runt‑related transcription factor 2 degradation

Authors:
- Xu Yan
- Hao Wang
- Yufei Li
- Yuxin Jiang
- Qingdong Shao
- Weidong Xu
View Affiliations

Affiliations: Department of Orthopedics, 455th Hospital of PLA, Shanghai 200052, P.R. China, Teaching Center of Experiment Medicine, Shanghai Medical College, Fudan University, Shanghai 200032, P.R. China, Department of Plastic Surgery, 455th Hospital of PLA, Shanghai 200052, P.R. China, School of Medicine, Dalian Medical University, Dalian, Liaoning 116044, P.R. China
Published online on: March 29, 2018 https://doi.org/10.3892/mmr.2018.8829
Pages: 7821-7826

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Bone mesenchymal stem cells (BMSCs) are an important source of stem cells for tissue repair and regeneration; therefore, understanding the mechanisms that regulate stem cell differentiation in a specific lineage is critical. Runt‑related transcription factor 2 (Runx2) is a bone‑specific transcription factor that serves an important role in promoting osteogenic differentiation. However, Runx2 protein levels are regulated by the ubiquitin‑proteasome pathway. Previous research has identified that Smad6 can interact with Runx2 and enhance Smurf1‑induced Runx2 degradation in a ubiquitin‑proteasome‑dependent manner. Bioinformatics analysis demonstrated that miR‑92a can target Smad6. To characterize the regulatory effect of miR‑92a on osteogenic differentiation of BMSCs and assess the interactive association between Smad6 and miR‑92a, BMSCs were obtained from mice and miR‑92a or Smad6 overexpression vectors were constructed. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blots were used to analyze the expression of miR‑92a and Smad6, and the luciferase reporter assay was used to examine the interaction between miR‑92a and Smad6. BMSCs were induced in osteogenic differentiation media for 21 days. The alkaline phosphatase activity was assessed and Alizarin Red histochemical staining was also performed. The results suggested that the expression of miR‑92a suppressed Smad6‑mediated Runx2 degradation by direct integration with the 3'‑UTR of Smad6 mRNA, which was confirmed by a luciferase reporter assay. In addition, the expression of miR‑92a promoted the osteogenic differentiation of BMSCs. However, the regulatory effect of miR‑92a was inhibited by overexpression of Smad6. Taken together, the results suggest that miR‑92a expression inhibits the osteogenic differentiation of BMSCs by targeting Smad6.

View Figures

View References

1	Zheng YH, Xiong W, Su K, Kuang SJ and Zhang ZG: Multilineage differentiation of human bone marrow mesenchymal stem cells in vitro and in vivo. Exp Ther Med. 5:1576–1580. 2013. View Article : Google Scholar : PubMed/NCBI
2	Zhang L, Tang Y, Zhu X, Tu T, Sui L, Han Q, Yu L, Meng S, Zheng L, Valverde P, et al: Overexpression of MiR-335-5p promotes bone formation and regeneration in mice. J Bone Miner Res. 32:2466–2475. 2017. View Article : Google Scholar : PubMed/NCBI
3	Kim MJ, Park JS, Kim S, Moon SH, Yang HN, Park KH and Chung HM: Encapsulation of bone morphogenic protein-2 with Cbfa1-overexpressing osteogenic cells derived from human embryonic stem cells in hydrogel accelerates bone tissue regeneration. Stem Cells Dev. 20:1349–1358. 2011. View Article : Google Scholar : PubMed/NCBI
4	Kidwai F, Edwards J, Zou L and Kaufman DS: Fibrinogen induces RUNX2 activity and osteogenic development from human pluripotent stem cells. Stem Cells. 34:2079–2089. 2016. View Article : Google Scholar : PubMed/NCBI
5	Wang C, Liu D, Zhang C, Sun J, Feng W, Liang XJ, Wang S and Zhang J: Defect-related luminescent hydroxyapatite-enhanced osteogenic differentiation of bone mesenchymal stem cells via an ATP-induced cAMP/PKA pathway. ACS Appl Mater Interfaces. 8:11262–11271. 2016. View Article : Google Scholar : PubMed/NCBI
6	Inada M, Yasui T, Nomura S, Miyake S, Deguchi K, Himeno M, Sato M, Yamagiwa H, Kimura T, Yasui N, et al: Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn. 214:279–290. 1999. View Article : Google Scholar : PubMed/NCBI
7	Kim IS, Otto F, Zabel B and Mundlos S: Regulation of chondrocyte differentiation by Cbfa1. Mech Dev. 80:159–170. 1999. View Article : Google Scholar : PubMed/NCBI
8	Enomoto H, Enomoto-Iwamoto M, Iwamoto M, Nomura S, Himeno M, Kitamura Y, Kishimoto T and Komori T: Cbfa1 is a positive regulatory factor in chondrocyte maturation. J Biol Chem. 275:8695–8702. 2000. View Article : Google Scholar : PubMed/NCBI
9	Takeda S, Bonnamy JP, Owen MJ, Ducy P and Karsenty G: Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev. 15:467–481. 2001. View Article : Google Scholar : PubMed/NCBI
10	Ueta C, Iwamoto M, Kanatani N, Yoshida C, Liu Y, Enomoto-Iwamoto M, Ohmori T, Enomoto H, Nakata K, Takada K, et al: Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes. J Cell Biol. 153:87–100. 2001. View Article : Google Scholar : PubMed/NCBI
11	Stricker S, Fundele R, Vortkamp A and Mundlos S: Role of Runx genes in chondrocyte differentiation. Dev Biol. 245:95–108. 2002. View Article : Google Scholar : PubMed/NCBI
12	Shen R, Chen M, Wang YJ, Kaneki H, Xing L, O'keefe RJ and Chen D: Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation. J Biol Chem. 281:3569–3576. 2006. View Article : Google Scholar : PubMed/NCBI
13	Fan QM, Yue B, Bian ZY, Xu WT, Tu B, Dai KR, Li G and Tang TT: The CREB-Smad6-Runx2 axis contributes to the impaired osteogenesis potential of bone marrow stromal cells in fibrous dysplasia of bone. J Pathol. 228:45–55. 2012.PubMed/NCBI
14	Zhang L, Chen P, Chen L, Weng T, Zhang S, Zhou X, Zhang B and Liu L: Inhibited Wnt signaling causes age-dependent abnormalities in the bone matrix mineralization in the Apert syndrome FGFR2(S252W/+) mice. PLoS One. 10:e1127162015. View Article : Google Scholar : PubMed/NCBI
15	Chen S, Gluhak-Heinrich J, Wang YH, Wu YM, Chuang HH, Chen L, Yuan GH, Dong J, Gay I and MacDougall M: Runx2, osx, and dspp in tooth development. J Dent Res. 88:904–909. 2009. View Article : Google Scholar : PubMed/NCBI
16	Du J, Wang Q, Yang P and Wang X: FHL2 mediates tooth development and human dental pulp cell differentiation into odontoblasts, partially by interacting with Runx2. J Mol Histol. 47:195–202. 2016. View Article : Google Scholar : PubMed/NCBI
17	Lee YS, Park JS, Kim JH, Jung SM, Lee JY, Kim SJ and Park SH: Smad6-specific recruitment of Smurf E3 ligases mediates TGF-β1-induced degradation of MyD88 in TLR4 signalling. Nat Commun. 2:4602011. View Article : Google Scholar : PubMed/NCBI
18	Ducy P, Zhang R, Geoffroy V, Ridall AL and Karsenty G: Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell. 89:747–754. 1997. View Article : Google Scholar : PubMed/NCBI
19	Komori T: Runx2, a multifunctional transcription factor in skeletal development. J Cell Biochem. 87:1–8. 2002. View Article : Google Scholar : PubMed/NCBI
20	Li Y, Kong D, Ahmad A, Bao B and Sarkar FH: Targeting bone remodeling by isoflavone and 3,3′-diindolylmethane in the context of prostate cancer bone metastasis. PLoS One. 7:e330112012. View Article : Google Scholar : PubMed/NCBI